5-Aminolevulinic acid



Compound IDCDAMM01950
Common name5-Aminolevulinic acid
IUPAC name5-amino-4-oxopentanoic acid
Molecular formulaC5H9NO3

Experimental data

Retention time14.74
Adduct[2M+K]+
Actual mz301.081
Theoretical mz301.079
Error5.79
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.0281

Identifiers and class information

Inchi keyZGXJTSGNIOSYLO-UHFFFAOYSA-N
SmilesO=C(O)CCC(=O)CN
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)131.131
Computed dipole moment(dipole)5.027
Total solvent accessible surface area (SASA)329.915
Hydrophobic component of SASA (FOSA)119.632
Hydrophilic component of SASA (FISA)210.283
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)498.706
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)5
Free energy of solvation of dipole (dip^2/V)0.050667
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0262499
Globularity descriptor (glob)0.921848
Predicted polarizability in cubic angstroms (QPpolrz)10.594
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.038
Predicted octanol/gas partition coefficient (QPlogPoct)10.767
Predicted water/gas partition coefficient (QPlogPw)10.159
Predicted octanol/water partition coefficient (QPlogPo/w)-2.962
Predicted aqueous solubility (QPlogS)0.099
Conformation-independent predicted aqueous solubility (CIQPlogS)0.507
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-1.715
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)6.343
Predicted brain/blood partition coefficient (QPlogBB)-0.989
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2.932
Predicted skin permeability, log Kp (QPlogKp)-6.978
PM3 calculated ionization potential (IP(ev))10.188
PM3 calculated electron affinity (EA(eV))0.045
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.061
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)23.96
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)106.061
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P24046GABRR1GABA receptor rho-1 subunitT99665SEA
O75899GABBR2GABA-B receptorT42446SEA
P48066SLC6A11GABA transporter 3T38200SEA
O75899GABBR2GABA-B receptorT42446SEA
Q4U2R8SLC22A6Solute carrier family 22 member 6 (by homology)T70680SEA
Q6B0I6KDM4DLysine-specific demethylase 4DT17036SEA
P48065SLC6A12Betaine transporterT08446SwissTargetPrediction
Q07075ENPEPAminopeptidase AT31956SEA
P41229KDM5CLysine-specific demethylase 5CT85540SEA
Q9Y2K7KDM2ALysine-specific demethylase 2AT71949SEA
Q6ZMT4KDM7ALysine-specific demethylase 7A/7BT18784SEA
Q9UPP1PHF8Histone lysine demethylase PHF8T00933SEA
Q4U2R8SLC22A6Solute carrier family 22 member 6 (by homology)T70680SEA
Q9UN88GABRQGABA(A) receptor thetaT15161SEA
P78329CYP4F2Cytochrome P450 4fT82604SEA
O60603TLR2Toll-like receptor 2T82078SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T38200DI0207Indeterminate colitis[ICD-11: DD72]P48066SLC6A11
T42446DI0117Depression[ICD-11: 6A70-6A7Z]O75899GABBR2
T42446DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]O75899GABBR2
T42446DI0275Multiple sclerosis[ICD-11: 8A40]O75899GABBR2
T42446DI0290Narcolepsy[ICD-11: 7A20]O75899GABBR2
T70680DI0167Gout[ICD-11: FA25]Q4U2R8SLC22A6
T70680DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]Q4U2R8SLC22A6
T70680DI0310Ocular disease[ICD-11: N.A.]Q4U2R8SLC22A6
T31956DI0190Hypertension[ICD-11: BA00-BA04]Q07075ENPEP
T70680DI0167Gout[ICD-11: FA25]Q4U2R8SLC22A6
T70680DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]Q4U2R8SLC22A6
T70680DI0310Ocular disease[ICD-11: N.A.]Q4U2R8SLC22A6
T82078DI0346Prostate cancer[ICD-11: 2C82]O60603TLR2

Copyright © 2025